Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors

Identifieur interne : 000670 ( Main/Merge ); précédent : 000669; suivant : 000671

Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors

Auteurs : Seri Jo ; Hyojin Kim ; Suwon Kim ; Dong Hae Shin ; Mi-Sun Kim

Source :

RBID : PMC:7162010

Abstract

Abstract

Middle East respiratory syndrome‐coronavirus (MERS‐CoV) is a zoonotic virus transmitted between animals and human beings. It causes MERS with high mortality rate. However, no vaccine or specific treatment is currently available. Since antiviral activity of some flavonoids is known, we applied a flavonoid library to probe inhibitory compounds against MERS‐CoV 3C‐like protease (3CLpro). Herbacetin, isobavachalcone, quercetin 3‐β‐d‐glucoside and helichrysetin were found to block the enzymatic activity of MERS‐CoV 3CLpro. The binding of the four flavonoids was also confirmed independently using a tryptophan‐based fluorescence method. The systematic comparison of the binding affinity of flavonoids made it possible to infer their scaffolds and functional groups required to bind with MERS‐CoV 3CLpro. An induced‐fit docking analysis revealed that S1 and S2 sites play a role in interaction with flavonoids. The experimental and computational study showed that flavonol and chalcone are favourite scaffolds to bind with the catalytic site of MERS‐CoV 3CLpro. It was also deduced that some flavonoid derivatives with hydrophobic or carbohydrate attached to their core structures have a good inhibitory effect. Therefore, we suggest that flavonoids with these characteristics can be used as templates to develop potent MERS‐CoV 3CLpro inhibitors.


Url:
DOI: 10.1111/cbdd.13604
PubMed: 31436895
PubMed Central: 7162010

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:7162010

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors</title>
<author>
<name sortKey="Jo, Seri" sort="Jo, Seri" uniqKey="Jo S" first="Seri" last="Jo">Seri Jo</name>
<affiliation>
<nlm:aff id="cbdd13604-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kim, Hyojin" sort="Kim, Hyojin" uniqKey="Kim H" first="Hyojin" last="Kim">Hyojin Kim</name>
<affiliation>
<nlm:aff id="cbdd13604-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kim, Suwon" sort="Kim, Suwon" uniqKey="Kim S" first="Suwon" last="Kim">Suwon Kim</name>
<affiliation>
<nlm:aff id="cbdd13604-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shin, Dong Hae" sort="Shin, Dong Hae" uniqKey="Shin D" first="Dong Hae" last="Shin">Dong Hae Shin</name>
<affiliation>
<nlm:aff id="cbdd13604-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kim, Mi Un" sort="Kim, Mi Un" uniqKey="Kim M" first="Mi-Sun" last="Kim">Mi-Sun Kim</name>
<affiliation>
<nlm:aff id="cbdd13604-aff-0001"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">31436895</idno>
<idno type="pmc">7162010</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162010</idno>
<idno type="RBID">PMC:7162010</idno>
<idno type="doi">10.1111/cbdd.13604</idno>
<date when="2019">2019</date>
<idno type="wicri:Area/Pmc/Corpus">000B62</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000B62</idno>
<idno type="wicri:Area/Pmc/Curation">000B62</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000B62</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000378</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000378</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:31436895</idno>
<idno type="wicri:Area/PubMed/Corpus">000446</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000446</idno>
<idno type="wicri:Area/PubMed/Curation">000446</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000446</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000642</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000642</idno>
<idno type="wicri:Area/Ncbi/Merge">002314</idno>
<idno type="wicri:Area/Ncbi/Curation">002314</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002314</idno>
<idno type="wicri:doubleKey">1747-0277:2019:Jo S:characteristics:of:flavonoids</idno>
<idno type="wicri:Area/Main/Merge">000670</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors</title>
<author>
<name sortKey="Jo, Seri" sort="Jo, Seri" uniqKey="Jo S" first="Seri" last="Jo">Seri Jo</name>
<affiliation>
<nlm:aff id="cbdd13604-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kim, Hyojin" sort="Kim, Hyojin" uniqKey="Kim H" first="Hyojin" last="Kim">Hyojin Kim</name>
<affiliation>
<nlm:aff id="cbdd13604-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kim, Suwon" sort="Kim, Suwon" uniqKey="Kim S" first="Suwon" last="Kim">Suwon Kim</name>
<affiliation>
<nlm:aff id="cbdd13604-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shin, Dong Hae" sort="Shin, Dong Hae" uniqKey="Shin D" first="Dong Hae" last="Shin">Dong Hae Shin</name>
<affiliation>
<nlm:aff id="cbdd13604-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kim, Mi Un" sort="Kim, Mi Un" uniqKey="Kim M" first="Mi-Sun" last="Kim">Mi-Sun Kim</name>
<affiliation>
<nlm:aff id="cbdd13604-aff-0001"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Chemical Biology & Drug Design</title>
<idno type="ISSN">1747-0277</idno>
<idno type="eISSN">1747-0285</idno>
<imprint>
<date when="2019">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<title>Abstract</title>
<p>Middle East respiratory syndrome‐coronavirus (MERS‐CoV) is a zoonotic virus transmitted between animals and human beings. It causes MERS with high mortality rate. However, no vaccine or specific treatment is currently available. Since antiviral activity of some flavonoids is known, we applied a flavonoid library to probe inhibitory compounds against MERS‐CoV 3C‐like protease (3CLpro). Herbacetin, isobavachalcone, quercetin 3‐β‐
<sc>d</sc>
‐glucoside and helichrysetin were found to block the enzymatic activity of MERS‐CoV 3CLpro. The binding of the four flavonoids was also confirmed independently using a tryptophan‐based fluorescence method. The systematic comparison of the binding affinity of flavonoids made it possible to infer their scaffolds and functional groups required to bind with MERS‐CoV 3CLpro. An induced‐fit docking analysis revealed that S1 and S2 sites play a role in interaction with flavonoids. The experimental and computational study showed that flavonol and chalcone are favourite scaffolds to bind with the catalytic site of MERS‐CoV 3CLpro. It was also deduced that some flavonoid derivatives with hydrophobic or carbohydrate attached to their core structures have a good inhibitory effect. Therefore, we suggest that flavonoids with these characteristics can be used as templates to develop potent MERS‐CoV 3CLpro inhibitors.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000670 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000670 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     PMC:7162010
   |texte=   Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i   -Sk "pubmed:31436895" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021